View all Webinars

Schwegman Lundberg & Woessner

Close     Close Mobile Menu

Innovation Act Stalls in the House

iStock_000001499158_SmallRepresentative Goodlatte’s Innovation Act (H.R. 9) has been shelved for now, and will not receive a floor vote until September at the earlier. There is significant conflict between measures intended to deter patent trolls and the ability of non-profit institutional NPE’s to enforce their patents. Big Pharma wants “out” of IPR entirely.  Action on the corresponding Senate Bill,  S. 1137, will also be postponed.

A 3-page chart comparing major provisions of the bill with IPO positions is available on the IPO website. 

Share
WoessnerWarrenWebsite
Author:
Principal


  Back to All Resources